BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32513205)

  • 1. Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
    Trone JC; Vallard A; Sotton S; Ben Mrad M; Jmour O; Magné N; Pommier B; Laporte S; Ollier E
    Radiat Oncol; 2020 Jun; 15(1):145. PubMed ID: 32513205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.
    Shah JL; Li G; Shaffer JL; Azoulay MI; Gibbs IC; Nagpal S; Soltys SG
    Neurosurgery; 2018 Jan; 82(1):24-34. PubMed ID: 28605463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis.
    Guo L; Li X; Chen Y; Liu R; Ren C; Du S
    Cancer Radiother; 2021 Apr; 25(2):182-190. PubMed ID: 33436285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Hypofractionation Radiation Strategies for Glioblastoma.
    Azoulay M; Shah J; Pollom E; Soltys SG
    Curr Oncol Rep; 2017 Sep; 19(9):58. PubMed ID: 28735440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years.
    Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y
    Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of hypofractionated radiation therapy in older glioblastoma patients.
    Nead KT; Swisher-McClure S
    J Geriatr Oncol; 2019 Jan; 10(1):155-158. PubMed ID: 30017732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques.
    Matsui JK; Perlow HK; Facer BD; McCalla A; Marrazzo L; Detti B; Scorsetti M; Clerici E; Scoccianti S; Navarria P; Trifiletti DM; Gondi V; Bovi J; Huang J; Brown PD; Palmer JD
    Chin Clin Oncol; 2022 Oct; 11(5):38. PubMed ID: 36336897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients over 70 Years Old with Newly Diagnosed Glioblastoma.
    Yusuf M; Ugiliweneza B; Amsbaugh M; Boakye M; Williams B; Nelson M; Hattab EM; Woo S; Burton E
    Oncology; 2018; 95(1):39-42. PubMed ID: 29694955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic parameters and outcome after re-irradiation for progressive glioblastoma.
    Zwirner K; Paulsen F; Schittenhelm J; Borchers C; Skardelly M; Zips D; Eckert F
    Acta Neurol Scand; 2017 Sep; 136(3):239-245. PubMed ID: 28025828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM).
    Brehmer S; Grimm MA; Förster A; Seiz-Rosenhagen M; Welzel G; Stieler F; Wenz F; Groden C; Mai S; Hänggi D; Giordano FA
    Neurosurgery; 2019 May; 84(5):1133-1137. PubMed ID: 29688510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database.
    Mak KS; Agarwal A; Qureshi MM; Truong MT
    Cancer Med; 2017 Jun; 6(6):1192-1200. PubMed ID: 28440040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
    Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
    Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.
    Pedretti S; Masini L; Turco E; Triggiani L; Krengli M; Meduri B; Pirtoli L; Borghetti P; Pegurri L; Riva N; Gatta R; Fusco V; Scoccianti S; Bruni A; Ricardi U; Santoni R; Magrini SM; Buglione M
    J Neurooncol; 2019 Jul; 143(3):447-455. PubMed ID: 31054101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiation therapy and temozolomide in patients with glioblastoma and poor prognostic factors. A prospective, single-institution experience.
    Jablonska PA; Diez-Valle R; Pérez-Larraya JG; Moreno-Jiménez M; Idoate MÁ; Arbea L; Tejada S; Garcia de Eulate MR; Ramos L; Arbizu J; Domínguez P; Aristu JJ
    PLoS One; 2019; 14(6):e0217881. PubMed ID: 31170245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External beam radiation dose escalation for high grade glioma.
    Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
    Cochrane Database Syst Rev; 2016 Aug; (8):CD011475. PubMed ID: 27541334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.